Ticker
TVRDCompany Name
TVARDI THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -31.58M | -480% | $ 6.58M |
3/31/2025 | $ -35.16M | -464.35% | $ 7.57M |
12/31/2024 | $ -60.92M | -853.54% | $ 7.14M |
9/30/2024 | $ -74.24M | -854.75% | $ 8.69M |
6/30/2024 | $ -79.91M | -726.67% | $ 11M |
3/31/2024 | $ -87.91M | -519.03% | $ 16.94M |
12/31/2023 | $ -92.08M | -439.14% | $ 20.97M |
9/30/2023 | $ -98.22M | -462.75% | $ 21.23M |
6/30/2023 | $ -103.77M | -381.88% | $ 27.17M |
3/31/2023 | $ -87.82M | -203.1% | $ 43.24M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for TVARDI THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -118.74M ] / Revenues [ $ 27.5M ]
(=) OCF % [ -431.72% ]
Minimum
Sep 30, 2024
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 78.12% |
average | 14.36% |
median | 12.67% |
std | 21.14% |